Read More Pharma Industry News Australia kills Cosette’s Mayne Pharma (ASX: MYX) buyout—citing drug supply risk and sovereignty Australia blocks Cosette’s $430M bid to acquire Mayne Pharma, citing critical medicine supply risks. Find out what triggered the decision and future implications. bySrinathNovember 22, 2025